Caxton Corp
- SEC CIK
- 0001388551
- Latest filing
- Aug 13, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 9
- +2 vs. Q2 2023
- Portfolio value
- $26.3M
- −$8.33M (−24.0%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SVRASavara Inc | COM | 3,313,602 | $12.5M | 47.6% | −1,667,202−33.5% | Reduced | History |
| XERSXeris Biopharma Holdings, Inc. | COM | 5,641,920 | $10.5M | 39.9% | 00.0% | Unchanged | History |
| RZLTRezolute, Inc. | COM NEW | 1,318,967 | $1.74M | 6.6% | 00.0% | Unchanged | History |
| MTEMMolecular Templates, Inc. | COM NEW | 136,866 | $865.0K | 3.3% | 00.0% | UnchangedConverted for a 1-for-15 split | History |
| APGEApogee Therapeutics, Inc. | COM | 12,472 | $265.7K | 1.0% | +12,472 | New | History |
| CMPXCompass Therapeutics, Inc. | COM | 86,773 | $170.9K | 0.6% | +43,307+99.6% | Added | History |
| ACRSAclaris Therapeutics, Inc. | COM | 19,473 | $133.4K | 0.5% | +19,473 | New | History |
| ALLKAllakos Inc. | COM | 49,329 | $112.0K | 0.4% | +31,596+178.2% | Added | History |
| ELEVElevation Acquisition Group Inc. | COM | 21,813 | $14.5K | 0.1% | +88+0.4% | Added | History |